Insight Lifetech Co. Ltd. (688712.SS)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in CNYTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNY m | - | - | - | - | - | - | - | - |
| Operating profit | CNY m | - | |||||||
| Net profit | CNY m | - | - | - | - | - | - | - | - |
| EPS reported | CNY | - | |||||||
| Operating cashflow per share | CNY | - | |||||||
| Capex per share | CNY | - | |||||||
| FCF per share | CNY | - | |||||||
| Free cash flow | CNY m | - | |||||||
| Net debt | CNY m | - | |||||||
| Book value equity | CNY m | - | |||||||
| Book value per share | CNY | - | |||||||
| Number of shares | m | - | |||||||
| DPS (TTM paid) | CNY | - |
Financial summary
Financials in CNYTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | |||||||
| P/B LTM | x | - | |||||||
| P/S LTM | x | - | |||||||
| P/FCF LTM | x | - | |||||||
| EV/EBITDA LTM | x | - | |||||||
| EV/Sales LTM | x | - | |||||||
| Earnings Yield LTM | % | - | |||||||
| FCF Yield | % | - | |||||||
| Quality | |||||||||
| ROE | % | - | |||||||
| ROIC | % | - | |||||||
| Operating margin | % | - | |||||||
| Gross margin | % | - | |||||||
| FCF/Sales | % | - | |||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | |||||||
| Sales Growth YoY | % | - | |||||||
| Net Income Growth YoY | % | - | |||||||
| FCF Growth | % | - | |||||||
| Operating Profit Growth | % | - | |||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | - | |||||||
| Dividend Growth | % | - | |||||||
| Payout Ratio | % | - | |||||||
| FCF/Debt | x | - | |||||||
| Net Debt/EBITDA | x | - | |||||||
| EBIT/Net interest | x | - | |||||||
| Net debt/market cap | % | - | |||||||
| Net debt/Equity | x | - | |||||||
| Gross debt/equity | x | - | |||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Insight Lifetech Co., Ltd. operates as a medtech company. Its products include coronary physiology, coronary imaging, and coronary catheters. The firm also offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu, Song Liang and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Insight Lifetech Co. Ltd. (688712.SS)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Insight Lifetech Co., Ltd. operates as a medtech company. Its products include coronary physiology, coronary imaging, and coronary catheters. The firm also offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu, Song Liang and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free